Skip to main content
Top
Published in: European Journal of Pediatrics 4/2008

01-04-2008 | Short Report

False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia

Authors: Felix Schreiner, Christoph Brack, Kirsten Salzgeber, Walburga Vorhoff, Joachim Woelfle, Bettina Gohlke

Published in: European Journal of Pediatrics | Issue 4/2008

Login to get access

Abstract

We report 5 out of 214 children with classical congenital adrenal hyperplasia (CAH) that was not detected by neonatal 17-Hydroxyprogesterone screening. Therefore, diagnosis was only based on a suspect clinical picture and subsequent re-evaluation. In addition to 3 patients suffering from the simple virilizing form of CAH and not reported so far, the remaining 2 children whose CAH was missed by the screening suffered from the severe salt-wasting form. This report underlines the importance of a careful clinical investigation of newborns to detect signs of genital virilization. The differential diagnosis of classical CAH should be kept in mind even if neonatal screening is reported to be normal.
Literature
1.
go back to reference Gudmundsson K, Majzoub JA, Bradwin G, Mandel S, Rifai N (1999) Virilising 21-hydroxylase deficiency: timing of newborn screening and confirmatory tests can be crucial. J Pediatr Endocrinol Metab 12(6):895–901PubMed Gudmundsson K, Majzoub JA, Bradwin G, Mandel S, Rifai N (1999) Virilising 21-hydroxylase deficiency: timing of newborn screening and confirmatory tests can be crucial. J Pediatr Endocrinol Metab 12(6):895–901PubMed
2.
go back to reference Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85(3):1059–1065PubMedCrossRef Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85(3):1059–1065PubMedCrossRef
3.
go back to reference Rohrer TR, Gassmann KF, Pavel ME, Dorr HG (2003) Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Neonate 83(1):65–68PubMedCrossRef Rohrer TR, Gassmann KF, Pavel ME, Dorr HG (2003) Pitfall of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Biol Neonate 83(1):65–68PubMedCrossRef
4.
go back to reference Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90(2):584–595PubMedCrossRef Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90(2):584–595PubMedCrossRef
5.
go back to reference Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101(4 Pt 1):583–590PubMedCrossRef Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101(4 Pt 1):583–590PubMedCrossRef
6.
go back to reference Thilen A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A (1998) Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 101(4):E11CrossRef Thilen A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C, Larsson A (1998) Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 101(4):E11CrossRef
7.
go back to reference Votava F, Torok D, Kovacs J, Moslinger D, Baumgartner-Parzer SM, Solyom J, Pribilincova Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology—Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group (2005) Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur J Endocrinol 152(6):869–874PubMedCrossRef Votava F, Torok D, Kovacs J, Moslinger D, Baumgartner-Parzer SM, Solyom J, Pribilincova Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology—Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group (2005) Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur J Endocrinol 152(6):869–874PubMedCrossRef
8.
go back to reference Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80(8):2322–2329PubMedCrossRef Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80(8):2322–2329PubMedCrossRef
9.
go back to reference Woelfle J, Hoepffner W, Sippell WG, Bramswig JH, Heidemann P, Deiss D, Bokenkamp A, Roth C, Irle U, Wollmann HA, Zachmann M, Kubini K, Albers N (2002) Complete virilization in congenital adrenal hyperplasia: clinical course, medical management and disease-related complications. Clin Endocrinol (Oxf) 56(2):231–238CrossRef Woelfle J, Hoepffner W, Sippell WG, Bramswig JH, Heidemann P, Deiss D, Bokenkamp A, Roth C, Irle U, Wollmann HA, Zachmann M, Kubini K, Albers N (2002) Complete virilization in congenital adrenal hyperplasia: clinical course, medical management and disease-related complications. Clin Endocrinol (Oxf) 56(2):231–238CrossRef
10.
go back to reference Zabransky S, Schulze E, Heinrich UE (2001) Causes, clinical course, screening, and mutation analysis in congenital adrenal hyperplasia. In: Zabransky S (ed) Screening for inborn endocrine and metabolic disorders (Screening auf angeborene endokrine und metabole Störungen). Springer, Vienna, pp 181–195 Zabransky S, Schulze E, Heinrich UE (2001) Causes, clinical course, screening, and mutation analysis in congenital adrenal hyperplasia. In: Zabransky S (ed) Screening for inborn endocrine and metabolic disorders (Screening auf angeborene endokrine und metabole Störungen). Springer, Vienna, pp 181–195
Metadata
Title
False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia
Authors
Felix Schreiner
Christoph Brack
Kirsten Salzgeber
Walburga Vorhoff
Joachim Woelfle
Bettina Gohlke
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 4/2008
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-007-0505-0

Other articles of this Issue 4/2008

European Journal of Pediatrics 4/2008 Go to the issue